Krista Picha’s fourth-year Spanish students had a big day Friday, but they couldn’t be found anywhere in the classroom. That’s because they were down the hall in a kitchen ...

Immunome, Inc. (the "Company") (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class ...

Western drugmakers are striking more deals in China to access “bio-better” treatments for diseases from obesity to cancer, ...

Dubai: Saudi Arabia’s Ministry of Health has mandated that all Umrah pilgrims must receive a meningitis vaccine at least 10 days before their departure. This requirement is part of the latest health ...

OSANG Healthcare partners with KAIST, NANO to develop PCR tests for STIs Innovative partnership aims to enhance diagnostic ...

BioAtla, Inc., a biotechnology firm specializing in biological products, received notice from The Nasdaq Stock Market on Tuesday that it is at risk of being delisted. Currently trading at $0.45, the ...

SandboxAQ today announced it has expanded its relationship with Deloitte to offer SandboxAQ's AI LQM simulation products and solutions along with Deloitte's services capabilities to organizations ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

South Korea faces gender disparity in research with lowest female researcher ratio in OECD Research reveals pressing need for greater support and opportunities for female scientists in South Korea.

Scientists from Tomsk Polytechnic University together with their colleagues are researching two endangered Ob-Ugric languages ...

MRG007 is an antibody drug conjugate (ADC), a type of therapy made by linking a toxic drug payload to a targeting antibody. Lepu has not disclosed the target of the drug, nor has ArriVent.